跳至主要内容
临床试验/ACTRN12621001267842
ACTRN12621001267842招募中未知

Airoplane: Comparing the effect of 21% versus 30% oxygen for preterm infants on the need for ongoing respiratory support; an embedded trial

Murdoch Children's Research Institute0 个研究点目标入组 1,200 人开始时间: 2021年9月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
1,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
32 Weeks 至 35 Weeks(—)
性别
All

入选标准

  • Each infant must meet all of the follwing to be included in the study:
  • o born in a participating Victorian hospital across the 2 year trial period (2022/2023)
  • o born between at 32+0 and 35+6 weeks of gestation
  • o receive respiratory support in the delivery room to support transition, respiratory support includes any facemask support, such as for the provision of CPAP, intermittent positive pressure ventilation, intubation, or any combination of these interventions.

排除标准

  • Infants will be excluded if they:
  • oare born outside the criteria above, including those who do not receive respiratory support during transition
  • ohave any known major congenital cardiorespiratory or craniofacial anomaly likely to affect transition, or
  • oa prior decision has been made not to provide intensive care (i.e. comfort care),

研究者

相似试验